Mitchell Thorn

1.2k total citations
17 papers, 975 citations indexed

About

Mitchell Thorn is a scholar working on Immunology, Oncology and Small Animals. According to data from OpenAlex, Mitchell Thorn has authored 17 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 6 papers in Oncology and 2 papers in Small Animals. Recurrent topics in Mitchell Thorn's work include Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mitchell Thorn is often cited by papers focused on Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Mitchell Thorn collaborates with scholars based in United States, Denmark and Italy. Mitchell Thorn's co-authors include N. Joseph Espat, Steven C. Katz, Richard P. Junghans, Gary R. Point, Rachel A. Burga, Prajna Guha, Marissa Cunetta, Lauren A. Licata, Elise McCormack and Robin Davies and has published in prestigious journals such as Journal of Clinical Oncology, Biological Psychiatry and Clinical Cancer Research.

In The Last Decade

Mitchell Thorn

17 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell Thorn United States 12 718 432 220 186 168 17 975
Prajna Guha United States 14 734 1.0× 550 1.3× 230 1.0× 154 0.8× 631 3.8× 33 1.5k
Kevin Sek Australia 8 935 1.3× 749 1.7× 205 0.9× 159 0.9× 419 2.5× 11 1.3k
Árpád Szöőr Hungary 15 467 0.7× 218 0.5× 142 0.6× 116 0.6× 279 1.7× 58 774
Melissa A. Henderson Australia 12 1.1k 1.5× 818 1.9× 230 1.0× 182 1.0× 450 2.7× 17 1.5k
Megan M. Wyatt United States 14 537 0.7× 429 1.0× 103 0.5× 83 0.4× 190 1.1× 30 773
Lorinda Soma United States 14 947 1.3× 369 0.9× 241 1.1× 275 1.5× 374 2.2× 43 1.4k
Samuel Haile United States 10 559 0.8× 366 0.8× 154 0.7× 89 0.5× 202 1.2× 14 885
Stephanie Mgebroff United States 12 1.4k 1.9× 698 1.6× 334 1.5× 359 1.9× 380 2.3× 24 1.7k
Ekaterina Friebel Switzerland 8 358 0.5× 594 1.4× 110 0.5× 69 0.4× 272 1.6× 11 987

Countries citing papers authored by Mitchell Thorn

Since Specialization
Citations

This map shows the geographic impact of Mitchell Thorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Thorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Thorn more than expected).

Fields of papers citing papers by Mitchell Thorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Thorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Thorn. The network helps show where Mitchell Thorn may publish in the future.

Co-authorship network of co-authors of Mitchell Thorn

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Thorn. A scholar is included among the top collaborators of Mitchell Thorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Thorn. Mitchell Thorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nguyen, Hong-My, Mark Collinge, James Hickey, et al.. (2024). mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions. Molecular Therapy. 33(6). 2872–2885. 8 indexed citations
2.
Katz, Steven C., Gary R. Point, Marissa Cunetta, et al.. (2016). Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery. Cancer Gene Therapy. 23(5). 142–148. 137 indexed citations
3.
Thorn, Mitchell, Prajna Guha, Marissa Cunetta, et al.. (2016). Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases. Cancer Gene Therapy. 23(6). 188–198. 87 indexed citations
4.
Katz, Steven C., Rachel A. Burga, Elise McCormack, et al.. (2015). Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases. Clinical Cancer Research. 21(14). 3149–3159. 314 indexed citations
5.
Burga, Rachel A., Mitchell Thorn, Gary R. Point, et al.. (2015). Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Cancer Immunology Immunotherapy. 64(7). 817–829. 186 indexed citations
6.
Thorn, Mitchell, et al.. (2014). Evaluation of a novel delayed-type hypersensitivity assay toCandida albicansin adult and neonatal rats. Journal of Immunotoxicology. 12(4). 350–360. 4 indexed citations
7.
Saied, Abdul, Lauren A. Licata, Rachel A. Burga, et al.. (2014). Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases. Cancer Gene Therapy. 21(11). 457–462. 35 indexed citations
8.
Thorn, Mitchell, Gary R. Point, Rachel A. Burga, et al.. (2014). Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells. Journal of Leukocyte Biology. 96(5). 883–894. 15 indexed citations
9.
Collinge, Mark, et al.. (2013). Validation of aCandida albicansdelayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments. Journal of Immunotoxicology. 10(4). 341–348. 2 indexed citations
10.
Katz, Steven C., Rachel A. Burga, Lauren A. Licata, et al.. (2013). Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor. Journal of Translational Medicine. 11(1). 46–46. 21 indexed citations
11.
Licata, Lauren A., Cang T. Nguyen, Rachel A. Burga, et al.. (2013). Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. Journal of Leukocyte Biology. 94(4). 813–823. 32 indexed citations
12.
Burga, Rachel A., Mitchell Thorn, Cang T. Nguyen, et al.. (2013). Targeting myeloid-derived suppressor cells and the PD-1/PD-L1 axis to enhance immunotherapy with anti-CEA designer T cells for the treatment of colorectal liver metastases.. Journal of Clinical Oncology. 31(15_suppl). 3079–3079. 1 indexed citations
13.
Thorn, Mitchell, Nicole Piche‐Nicholas, Donald B. Stedman, et al.. (2012). Embryo‐Fetal Transfer of Bevacizumab (Avastin) in the Rat Over the Course of Gestation and the Impact of Neonatal Fc Receptor (FcRn) Binding. Birth Defects Research Part B Developmental and Reproductive Toxicology. 95(5). 363–375. 12 indexed citations
14.
Crupi, Rosalia, Marco Cambiaghi, Linda Spatz, et al.. (2010). Reduced Adult Neurogenesis and Altered Emotional Behaviors in Autoimmune-Prone B-Cell Activating Factor Transgenic Mice. Biological Psychiatry. 67(6). 558–566. 51 indexed citations
15.
Thorn, Mitchell, et al.. (2009). BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion. Cellular Immunology. 261(1). 9–22. 26 indexed citations
16.
Taylor, Devon K., et al.. (2006). Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19☆. Molecular Immunology. 43(11). 1776–1790. 11 indexed citations
17.
Forchhammer, Lykke, et al.. (2003). Immunobiological Effects of Glucosamine In Vitro. Scandinavian Journal of Immunology. 58(4). 404–411. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prajna Guha Breakdown of academic impact, for papers by Kevin Sek Breakdown of academic impact, for papers by Árpád Szöőr Breakdown of academic impact, for papers by Melissa A. Henderson Breakdown of academic impact, for papers by Megan M. Wyatt Breakdown of academic impact, for papers by Lorinda Soma Breakdown of academic impact, for papers by Samuel Haile Breakdown of academic impact, for papers by Stephanie Mgebroff Breakdown of academic impact, for papers by Ekaterina Friebel
Rankless by CCL
2026